Citation Impact
Citing Papers
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men.
1990
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
1999 StandoutNobel
Cardiovascular prevention and blood pressure reduction
2003
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine
1995 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Neighborhood of Residence and Incidence of Coronary Heart Disease
2001 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Targeted Disruption of the β2 Adrenergic Receptor Gene
1999 StandoutNobel
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Low-renin status in therapy-resistant hypertension
2004
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
Should there be a moratorium on the use of cholesterol lowering drugs?
1992
Use of β‐blockers is associated with prostate cancer‐specific survival in prostate cancer patients on androgen deprivation therapy
2012
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
High-Density Lipoprotein — The Clinical Implications of Recent Studies
1989
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients
2006
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Incidental Findings on Brain MRI in the General Population
2007 Standout
Socioeconomic Inequalities in Health in 22 European Countries
2008 Standout
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Effects of blood pressure lowering on outcome incidence in hypertension
2014
A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
1991
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
1994
The Influence of Oral Potassium Chloride on Blood Pressure in Hypertensive Men on a Low-Sodium Diet
1990
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
2005 Standout
Atherosclerosis
2000 StandoutNature
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
2001 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Social class, health behaviour, and mortality among men and women in eastern Finland
1995
Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
2000
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
1991 Standout
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Review of the Evidence on Fetal and Early Childhood Antecedents of Adult Chronic Disease
1996
A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with Hypertension
1989
Homocysteine and Atherothrombosis
1998 Standout
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage—foam cell accumulation independently of blood pressure and plasma lipids
1994
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
1998 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials
2014
Effects of antihypertensive therapy on serum lipoproteins.
1983
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
1989
Conflicting clinical trials and the uncertainty of treating mild hypertension
1983
Plasma High-Density Lipoproteins
1978
Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.
1993
Plasma catecholamines and essential hypertension. An analytical review.
1983
Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis.
1990
Cardiovascular Morbidity in Relation to Change in Blood Pressure and Serum Cholesterol Levels in Treated Hypertension
1987
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early Atherosclerosis
1986
Socioeconomic Inequalities in Cardiovascular Disease in an Ageing Population
1999
EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE
1981
Midwall Left Ventricular Mechanics
1996
Treatment of high blood pressure: should clinical practice be based on results of clinical trials?
1986
Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program
1986
The Decline in Ischemic Heart Disease Mortality Rates
1984
Smoking and its effects on body weight and the systems of caloric regulation
1982
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
All-cause mortality in the hypertension detection and follow-up program: Findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality
1986
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
1989 Standout
Secular Trends in Adult Physical Activity: Exercise Boom or Bust?
1987
Left ventricular mass and cardiovascular reactivity in young men.
1994
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
1996 StandoutScience
Blood pressure, stroke, and coronary heart disease
1990 Standout
Controlled clinical trials of drug treatment for hypertension. A review.
1989
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized controlled trials
1986
Socioeconomic factors and cardiovascular disease: a review of the literature.
1993
Physical Activity and the Incidence of Coronary Heart Disease
1987
Risk factors and atherosclerotic lesions. A review of autopsy studies.
1983
High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
1986
Effect of beta-adrenergic blockade on biochemical and metabolic response to exercise
1985
Blood Pressure and Stroke
2004
George Lyman Duff memorial lecture. Persistent problems in the pathogenesis of atherosclerosis.
1984
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Works of Anders Helgeland being referenced
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.
1978
Possible metabolic side effects of beta-adrenergic blocking drugs.
1978
Four-year mortality by some socioeconomic indicators: the Oslo study.
1980
The Oslo study: CHD risk factors, socioeconomic influences, and intervention
1983
Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries. Statistical analysis from the Oslo study.
1981
The Intercorrelation of Serum Cholsterol, Cigarette Smoking and Body Weight
1976
The Oslo study: Diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men
1985
Antihypertensive Drugs and Blood Lipids
1982
Increased Peripheral Release of Noradrenaline and Uptake of Adrenaline in Essential Hypertension?
1981
High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.
1979
Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension
1982
Serum glucose levels during long-term observation of treated and untreated men with mild hypertension
1984
Oslo Hypertension Study
1986
HDL‐cholesterol in antihypertensive treatment. The Oslo Study
1979
Treatment of mild hypertension: A five year controlled drug trial
1980
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension
1978
Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension
1982
The effect of dietary changes on high density lipoprotein cholesterol
1979
FOUR AND TWO-THIRDS YEARS INCIDENCE OF CORONARY HEART DISEASE IN MIDDLE-AGED MEN: THE OSLO STUDY
1980
The Oslo study. Cardiovascular disease in middle-aged and young Oslo men.
1975
Physical Activity at Work and at Leisure in Relation to Coronary Risk Factors and Social Class
1981
Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study.
1985
Antihypertensive drugs and blood lipids: the Oslo study.
1982
Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death
1985
EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDS
1980
Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT.
1984
The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study.
1976